SCHEMBL8420243

SCHEMBL8420243

CCCCC(NC(=O)[C@H](C)Nc1cnc2ccccc2c1)C(=O)OC.CCCCC(NC(=O)[C@H](C)Nc1nc2ccccc2s1)C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 1/20 0.43
NFKB1 P19838 1/20 0.43
CYP2C19 P33261 1/20 0.43
STAT1 P42224 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
HDAC4 P56524 3/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC3 O15379 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677141 0.91 HDAC4 (0.47) RAB9ASMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL7677145 0.91 HDAC4 (0.47) RAB9ASMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL7677293 0.91 HDAC4 (0.47) RAB9ASMN1; SMN2HDAC4HDAC1HDAC3
SCHEMBL7671786 0.90 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1CYP1A2
SCHEMBL7680226 0.90 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1CYP1A2
SCHEMBL7671781 0.90 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1CYP1A2
SCHEMBL7674164 0.70 TAS1R3 (0.43) HDAC2
SCHEMBL7675003 0.70 TAS1R3 (0.49) HDAC2MAPK1
SCHEMBL7679570 0.70 TAS1R3 (0.49) HDAC2MAPK1
SCHEMBL7677243 0.70 TAS1R3 (0.43) HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942923-A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS Elan Pharmaceuticals, Inc. (US) 1999-09-22 EP claimed
WO-1998022493-A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 1998-05-28 WO claimed